Montero Alberto相关文献与解析，生知库 | 链接生命科学的每一步

日期影响因子

Real-world outcomes of reduced-dose versus standard-dose antibody drug conjugates in metastatic breast cancer: a retrospective cohort study

转移性乳腺癌中低剂量与标准剂量抗体药物偶联物真实世界疗效比较：一项回顾性队列研究

期刊:Breast Cancer Research and Treatment

doi:10.1007/s10549-025-07891-4

Stabellini, Nickolas; Kaur, Jasskiran; Owusu, Cynthia; Moftakhar, Bahar; Mizukami, Takae; de Oliveira, Sonia D; Montero, Alberto J

发表日期：2026

文献求助收藏

A Phase II Randomized Study of Paclitaxel Alone or Combined with Pelareorep with or without Avelumab in Metastatic Hormone Receptor-Positive Breast Cancer: The BRACELET-01/PrE0113 Study

一项评估紫杉醇单药或联合Pelareorep（加或不加Avelumab）治疗转移性激素受体阳性乳腺癌的II期随机研究：BRACELET-01/PrE0113研究

期刊:Clinical Cancer Research

影响因子:10.2

doi:10.1158/1078-0432.CCR-24-2701

Clark, Amy S; Zhao, Fengmin; Klein, Paula; Montero, Alberto J; Falkson, Carla; Krill-Jackson, Elisa; Rowland, Kendrith; Sardesai, Sagar; Incorvati, Jason; Dillon, Patrick; Wolff, Antonio C; Trauger, Richard; Heineman, Thomas C; Coffey, Matthew C; Miller, Kathy D

免疫/内分泌

发表日期：2025

文献求助收藏

MELK as a Mediator of Stemness and Metastasis in Aggressive Subtypes of Breast Cancer.

MELK 在侵袭性乳腺癌亚型中作为干细胞特性和转移的介质

期刊:International Journal of Molecular Sciences

影响因子:4.9

doi:10.3390/ijms26052245

McBean Breanna, Abou Zeidane Reine, Lichtman-Mikol Samuel, Hauk Benjamin, Speers Johnathan, Tidmore Savannah, Flores Citlally Lopez, Rana Priyanka S, Pisano Courtney, Liu Meilan, Santola Alyssa, Montero Alberto, Boyle Alan P, Speers Corey W

发育与干细胞

细胞生物学

发表日期：2025

文献求助收藏

A novel machine learning-based cancer-specific cardiovascular disease risk score among patients with breast, colorectal, or lung cancer

一种基于机器学习的新型癌症特异性心血管疾病风险评分，适用于乳腺癌、结直肠癌或肺癌患者

期刊:JNCI Cancer Spectrum

影响因子:4.1

doi:10.1093/jncics/pkaf016

Stabellini, Nickolas; Makram, Omar M; Kunhiraman, Harikrishnan Hyma; Daoud, Hisham; Shanahan, John; Montero, Alberto J; Blumenthal, Roger S; Aggarwal, Charu; Swami, Umang; Virani, Salim S; Noronha, Vanita; Agarwal, Neeraj; Dent, Susan; Guha, Avirup

心血管疾病

发表日期：2025

文献求助收藏

Stakeholder perspectives on the role of caregivers in cancer clinical trial decision-making: results of a qualitative study

利益相关者对照护者在癌症临床试验决策中作用的看法：一项定性研究的结果

期刊:Supportive Care in Cancer

doi:10.1007/s00520-025-09505-7

Blackstone, Eric C; Mazanec, Susan R; Daly, Barbara J; Dorth, Jennifer A; Montero, Alberto J; Aulisio, Mark P; Brandt, Patricia T; Foley, Helen; Loue, Sana

发表日期：2025

文献求助收藏

Responses to checkpoint inhibition in metastatic triple negative breast cancer driven by divergent myeloid phenotypes

转移性三阴性乳腺癌对免疫检查点抑制剂的反应受不同髓系表型驱动

doi:10.1038/s43856-025-00860-4

Wilkerson, Avia D; Juric, Ivan; Singh, Salendra; Rayman, Patricia A; Pavicic, Paul G Jr; Powers, Jennifer; Parthasarathy, Prerana Bangalore; Al-Hilli, Zahraa; Ko, Jennifer S; Chan, Timothy; Alban, Tyler; Montero, Alberto J; Diaz-Montero, C Marcela

免疫/内分泌

发表日期：2025

文献求助收藏

Whose Autonomy Matters? Using Relational Autonomy to Analyze Caregiver Roles in Decision-Making for Cancer Clinical Trials

谁的自主权最重要？运用关系自主性分析照护者在癌症临床试验决策中的角色

doi:10.1080/23294515.2025.2576829

Blackstone, Eric C; Mazanec, Susan R; Daly, Barbara J; Dorth, Jennifer A; Montero, Alberto J; Aulisio, Mark P; Brandt, Patricia T; Loue, Sana

发表日期：2025

文献求助收藏

Giredestrant for Estrogen Receptor-Positive, HER2-Negative, Previously Treated Advanced Breast Cancer: Results From the Randomized, Phase II acelERA Breast Cancer Study

Giredestrant 用于雌激素受体阳性、HER2 阴性、既往接受过治疗的晚期乳腺癌：来自随机、II 期 acelERA 乳腺癌研究的结果

期刊:Journal of Clinical Oncology

影响因子:41.9

doi:10.1200/JCO.23.01500

Martín, Miguel; Lim, Elgene; Chavez-MacGregor, Mariana; Bardia, Aditya; Wu, Jiong; Zhang, Qingyuan; Nowecki, Zbigniew; Cruz, Felipe Melo; Safin, Rustem; Kim, Sung-Bae; Schem, Christian; Montero, Alberto J; Khan, Sarah; Bandyopadhyay, Reeti; Moore, Heather M; Shivhare, Mahesh; Patre, Monika; Martinalbo, Jorge; Roncoroni, Laura; Pérez-Moreno, Pablo Diego; Sohn, Joohyuk

免疫/内分泌

发表日期：2024

文献求助收藏

Phase II Clinical Trial of Pembrolizumab and Chemotherapy Reveals Distinct Transcriptomic Profiles by Radiologic Response in Metastatic Triple-Negative Breast Cancer

帕博利珠单抗联合化疗的II期临床试验揭示了转移性三阴性乳腺癌放射学反应的不同转录组特征

期刊:Clinical Cancer Research

影响因子:10.2

doi:10.1158/1078-0432.CCR-23-1349

Wilkerson, Avia D; Parthasarathy, Prerana Bangalore; Stabellini, Nickolas; Mitchell, Carley; Pavicic, Paul G Jr; Fu, Pingfu; Rupani, Amit; Husic, Hana; Rayman, Patricia A; Swaidani, Shadi; Abraham, Jame; Budd, G Thomas; Moore, Halle; Al-Hilli, Zahraa; Ko, Jennifer S; Baar, Joseph; Chan, Timothy A; Alban, Tyler; Diaz-Montero, C Marcela; Montero, Alberto J

发表日期：2024

文献求助收藏

NSABP FB-10: a phase Ib/II trial evaluating ado-trastuzumab emtansine (T-DM1) with neratinib in women with metastatic HER2-positive breast cancer

NSABP FB-10：一项评估ado-trastuzumab emtansine (T-DM1)联合neratinib治疗HER2阳性转移性乳腺癌女性患者的Ib/II期临床试验

期刊:Breast Cancer Research

影响因子:5.6

doi:10.1186/s13058-024-01823-8

Jacobs, Samuel A; Wang, Ying; Abraham, Jame; Feng, Huichen; Montero, Alberto J; Lipchik, Corey; Finnigan, Melanie; Jankowitz, Rachel C; Salkeni, Mohamad A; Maley, Sai K; Puhalla, Shannon L; Piette, Fanny; Quinn, Katie; Chang, Kyle; Nagy, Rebecca J; Allegra, Carmen J; Vehec, Kelly; Wolmark, Norman; Lucas, Peter C; Srinivasan, Ashok; Pogue-Geile, Katherine L

发表日期：2024

文献求助收藏